Anil Achyuta
Investment Director @ TDK Ventures
Boston, United States
Anil Achyuta is a Series A investor at TDK Ventures in Boston focused on Manufacturing and Renewable Energy. Anil Achyuta is the Director of External Innovation at L’Oréal, where he invests in next-generation technologies in materials science, digital / skin health, and medical aesthetics. Previously, Anil advised GlaxoSmithKline's (GSK) Bioelectronics R&D division and their Venture Arm – Action Potential Ventures (APVC) as their AssociateConsulting Director (now a $750M joint venture between GSK and Google’s Verily). Anil also created, led, and launched GSK's $1M Innovation Challenge, an open global competition. The Innovation Challenge catalyzed several strategic privatepublic partnerships and was designed to closely complement President Obama's BRAIN Initiative.Before GSK, Anil worked at Draper’s Business Development leading strategic projects in lab-on-a-chip, tissue engineering, and implantable devices. In lab-on-a-chip devices arena, Anil co-led the liver and brain-on-a-chip concepts, where his team showed malarial infections inside the liver chip (Gates foundation funded project). For his technical and business achievements, Anil won the Outstanding Contributor of the Year award at Draper for three consecutive years in a row along with "Neuroengineering Contributor of the Year" in 2012 by Lab-on-a-chip, a top micro-device engineering journal.Anil holds a Ph.D. in Chemical Engineering and an M.B.A along with a Certificate in Venture Capital and Private Equity from Harvard Business School Executive Education. Anil also actively mentors over 3 start-ups in various areas and helps entrepreneurs in financing, product development, and business development strategy.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Anil Achyuta invests in
Stages Anil Achyuta invests in
Countries Anil Achyuta invests in
Investment Focus
Industry
- Manufacturing 3 (38%)
- Renewable Energy 3 (38%)
- Energy 2 (25%)
- Medical 1 (13%)
- Chemical 1 (13%)
Stage
- Series A 5 (63%)
- Series B 2 (25%)
- Seed 1 (13%)
Country
- United States 5 (63%)
- Australia 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Peak Energy
|
Peak Energy is on a mission to speed grid decarbonization by substantially cutting the cost of energy storage and establishing the United States as a global leader in the sodium-ion sector. | $55M / Series A / Jul 17, 2024 | |
|
Peak Energy
|
Peak Energy is on a mission to speed grid decarbonization by substantially cutting the cost of energy storage and establishing the United States as a global leader in the sodium-ion sector. | $10M / Seed / Oct 04, 2023 | |
Novalith Technologies
|
Novalith Technologies is a climate technology company that uses carbon dioxide to simplify lithium chemicals production. Novalith's LiCALTM lithium extraction technology uses significantly less equipment, chemical reagents, water and energy than conventional processing, which reduces capital and production costs. The direct use andsequestration of CO2 in producing lithium chemicals also produces a much smaller emissions footprint than existing and alternative processes. | $15.4M / Series A / Apr 17, 2023 | |
Fabric8Labs
|
Fabric8Labs developed a unique process that is an intuitive combination of two mature technologies: Stereo-Lithography and Electro-Deposition. | $52.8M / Series B / Feb 07, 2023 | |
AM Batteries
|
AM Batteries manufactures Li-ion batteries using solvent-free electrode manufacturing technology. The company was founded in 2016 and is headquartered in Chelmsford, Massachusetts. | $25M / Series A / Oct 25, 2022 | |
Verdagy
|
Verdagy is revolutionizing water electrolysis technology to facilitate large-scale green hydrogen production. Their solution achieves the lowest upfront capital costs and offers a competitive unit economics for production. Located in Moss Landing, California, Verdagy operates laboratory and pilot plant facilities to advance and rapidly scale itstechnology platform. | $25M / Series A / Feb 08, 2022 | |
|
Fabric8Labs
|
Fabric8Labs developed a unique process that is an intuitive combination of two mature technologies: Stereo-Lithography and Electro-Deposition. | $19.3M / Series A / Jul 20, 2021 | |
Exo
|
Exo is a medical device startup handheld ultrasound platform and AI for imaging and therapeutic applications. The company is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high-quality medical imaging. Exo empowers healthcare professionals to make critical,real-time decisions that improve patient outcomes.The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing, and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging. It also represents a giant leap in imaging and therapeutics technology one that will drive the development of high-performance products that are accessible, easy-to-use, and available at a price point never before possible. | $40M / Series B / Aug 20, 2020 |
Co-Investors
About TDK Ventures
TDK Ventures is a technology-focused venture fund based in San Jose, California. We invest globally in Seed to B-round startups that leverage fundamental material science to unlock an attractive and sustainable future for the world. We believe in a sustainable world where digital and energy transformation will improve billions of lives for thebetter. Our mission is to help accelerate learnings and contributions to society, investing in start-ups with similar idealism. We aim to find meaningful opportunities in early-stage technology, especially in Health & Wellness, next Generation Transportation, Robotics & Industrial, Mixed Reality, and the wider IoT market segments. Dielectrics, magnetics, MEMS, neuro-electricals, organic materials, piezoelectrics, semiconductors, and many other types of materials, TDK Ventures is looking for the hardest problems where we have a proven track record of solving since 1935 and are passionate to continue solving these challenges together with our global innovation partners.
TDK Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Anil Achyuta
Investment Director
|
|||
Nicolas Sauvage
President
|
|||
David Delfassy
Investment Director
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Anil Achyuta invest in?
Anil Achyuta invests primarily in Manufacturing, Renewable Energy and Energy startups, most often at Series A and Series B stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Anil Achyuta last invest?
The most recent investment recorded for Anil Achyuta closed in Jul 2024. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
